Sign in or create an account to add this stock to your watchlist.
About Gerresheimer (ETR:GXI)
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolETR:GXI
CUSIPN/A
Phone+49-211-618100
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins10.26%
Return on Equity20.68%
Return on Assets6.56%
Miscellaneous
EmployeesN/A
Outstanding Shares31,400,000
Gerresheimer (ETR:GXI) Frequently Asked Questions
What is Gerresheimer's stock symbol?
Gerresheimer trades on the ETR under the ticker symbol "GXI."
What price target have analysts set for GXI?
12 equities research analysts have issued 1 year target prices for Gerresheimer's shares. Their forecasts range from €52.50 to €78.00. On average, they expect Gerresheimer's stock price to reach €68.23 in the next year. View Analyst Ratings for Gerresheimer.
Who are some of Gerresheimer's key competitors?
Some companies that are related to Gerresheimer include Ansell (ANN), Enerplus (ERF), Advanced Medical Solutions (AMS), TransEnterix (TRXC), CRH Medical (CRHM), Tristel (TSTL), TSO3. (TOS), Clover (CLV), Bovie Medical (BVX), Infusystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), Akers Biosciences (AKR), Daxor (DXR) and Omega Diagnostics Group (ODX).
Who are Gerresheimer's key executives?
Gerresheimer's management team includes the folowing people:
- Mr. Rainer Beaujean, Speaker of the Management Board (Age 50)
- Mr. Andreas Schutte, Member of the Management Board (Age 56)
- Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 37)
- Dr. Lukas Burkhardt, Member of Management Board (Age 39)
- Ms. Severine Camp, Corp. Sr. Director of Investor Relations
Has Gerresheimer been receiving favorable news coverage?
Media stories about GXI stock have been trending somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Gerresheimer earned a media sentiment score of 0.06 on Accern's scale. They also gave news headlines about the company an impact score of 46.30 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
What is Gerresheimer's stock price today?
One share of GXI stock can currently be purchased for approximately €66.90.
How big of a company is Gerresheimer?
Gerresheimer has a market capitalization of $2.10 billion.
How can I contact Gerresheimer?
Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100.
MarketBeat Community Rating for Gerresheimer (GXI)
MarketBeat's community ratings are surveys of what our community members think about Gerresheimer and other stocks. Vote "Outperform" if you believe GXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Gerresheimer (ETR:GXI) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
12 Wall Street analysts have issued ratings and price targets for Gerresheimer in the last 12 months. Their average twelve-month price target is €68.23The high price target for GXI is €78.00 and the low price target for GXI is €52.50. There are currently 2 sell ratings, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.08 | 2.08 | 2.18 | 2.40 |
| Ratings Breakdown: | 2 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | €68.23 | €68.23 | €70.04 | €73.49 |
Gerresheimer (ETR:GXI) Consensus Price Target History
Gerresheimer (ETR:GXI) Analyst Ratings History
Show:
(Data available from 5/23/2016 forward)
Gerresheimer (ETR:GXI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Gerresheimer (ETR GXI) Insider Trading and Institutional Ownership History
Gerresheimer (ETR GXI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Gerresheimer (ETR GXI) News Headlines
| Source: |
|
Gerresheimer (ETR:GXI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Gerresheimer (ETR GXI) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
